An Open-Label, Randomized, Prospective, Comparative, Three-Arm Clinical Trial to Evaluate the Safety and Effectiveness of Apremilast with Three Different Titration Methods in Patients with Chronic Plaque Psoriasis in India

PURPOSE: To minimize adverse effects (AEs), apremilast is recommended to titrate at the initiation of therapy. But still, many patients experience AEs, resulting in discontinuation of therapy. As a result, many dermatologists have adapted to further titrate apremilast in different ways. The present...

Descripción completa

Detalles Bibliográficos
Autores principales: Viswanath, Vishalakshi, Joshi, Pradnya, Lawate, Prakash, Tare, Dakshata, Dhoot, Dhiraj, Mahadkar, Namrata, Barkate, Hanmant
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9041601/
https://www.ncbi.nlm.nih.gov/pubmed/35496380
http://dx.doi.org/10.2147/PTT.S357184

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9041601/
https://www.ncbi.nlm.nih.gov/pubmed/35496380
http://dx.doi.org/10.2147/PTT.S357184

Ejemplares similares